Daniel Trencher Sells 1,000 Shares of Teladoc Health, Inc. (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Daniel Trencher sold 1,000 shares of the business's stock in a transaction on Wednesday, April 17th. The shares were sold at an average price of $13.21, for a total transaction of $13,210.00. Following the completion of the sale, the insider now directly owns 26,192 shares in the company, valued at approximately $345,996.32. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Daniel Trencher also recently made the following trade(s):

• On Monday, March 18th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The shares were sold at an average price of $15.18, for a total transaction of $15,180.00.
• On Monday, March 4th, Daniel Trencher sold 6,780 shares of Teladoc Health stock. The shares were sold at an average price of $14.52, for a total transaction of $98,445.60.
• On Tuesday, February 20th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The shares were sold at an average price of $20.64, for a total transaction of $20,640.00.

Teladoc Health Stock Performance

Shares of NYSE:TDOC remained flat at $13.14 during mid-day trading on Wednesday. 3,941,198 shares of the company were exchanged, compared to its average volume of 4,707,107. The company has a market cap of $2.22 billion, a price-to-earnings ratio of -9.80 and a beta of 0.94. The stock has a fifty day moving average of $16.02 and a 200 day moving average of $18.02. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. Teladoc Health, Inc. has a 1-year low of $13.03 and a 1-year high of $30.41.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.22) by $0.05. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The business had revenue of $660.50 million during the quarter, compared to analysts' expectations of $670.79 million. During the same period in the prior year, the business earned ($0.23) EPS. Teladoc Health's revenue for the quarter was up 3.6% compared to the same quarter last year. On average, equities analysts anticipate that Teladoc Health, Inc. will post -1.07 EPS for the current fiscal year.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds have recently made changes to their positions in the business. Counterpoint Mutual Funds LLC bought a new position in shares of Teladoc Health during the 1st quarter worth approximately $271,000. Ignite Planners LLC grew its stake in shares of Teladoc Health by 6.9% in the first quarter. Ignite Planners LLC now owns 13,307 shares of the health services provider's stock valued at $198,000 after buying an additional 857 shares in the last quarter. Banque Cantonale Vaudoise bought a new position in shares of Teladoc Health in the first quarter valued at $1,553,000. Avondale Wealth Management bought a new position in shares of Teladoc Health in the first quarter valued at $121,000. Finally, Nomura Holdings Inc. bought a new position in shares of Teladoc Health in the fourth quarter valued at $220,000. 76.82% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on TDOC shares. Piper Sandler lowered their target price on shares of Teladoc Health from $30.00 to $25.00 and set an "overweight" rating on the stock in a report on Wednesday, February 21st. Canaccord Genuity Group lowered their target price on shares of Teladoc Health from $34.00 to $28.00 and set a "buy" rating on the stock in a report on Wednesday, February 21st. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a report on Friday, April 5th. Royal Bank of Canada decreased their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an "outperform" rating on the stock in a report on Wednesday, February 21st. Finally, DA Davidson decreased their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a "neutral" rating on the stock in a report on Wednesday, February 21st. Eight research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $22.23.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.